Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup
Clinical trial NCT00579345 · COMPLETED
Trial details
- NCT number
- NCT00579345
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-06-01
- Enrollment
- 1522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.